Location History:
- Toulouse, FR (1977 - 1985)
- Garonne, FR (1985)
- Portet/Garonne, FR (1988 - 1998)
- Portet, FR (1982 - 2002)
- Portet-sur-Garonne, FR (1981 - 2007)
- Paris, FR (2015)
Company Filing History:
13 out of 25 
10 out of 1,451 
6 out of 44 
Years Active: 1977-2015
Title: Jean-Pierre Maffrand: A Prolific Innovator in Pharmaceutical Chemistry
Introduction
Jean-Pierre Maffrand is a distinguished inventor based in Portet/Garonne, France, known for his remarkable contributions to pharmaceutical chemistry. With an impressive portfolio of 36 patents, Maffrand has played a vital role in advancing therapeutic innovations, particularly in the realm of receptor agonists and novel compounds for medicinal use.
Latest Patents
Maffrand's latest patents showcase his inventive prowess and focus on bioactive compounds. One of his notable inventions is the development of FGF-receptor agonist dimeric compounds. These compounds are characterized by the general formula M1-L-M2, where M1 and M2 represent monomer units and L indicates a linker group. This innovation holds potential for therapeutic applications in various medical conditions.
Another significant patent revolves around Acylaminothiazole derivatives, their preparation, and therapeutic use. This compound, described by complex general formulas, includes a range of substituents such as halogens and alkyl groups. These derivatives are not only versatile but also represent an exciting avenue for medical therapy, marking Maffrand's ongoing commitment to improving health outcomes through innovative chemistry.
Career Highlights
Throughout his career, Jean-Pierre Maffrand has been associated with prominent companies such as Parcor and Sanofi. His tenure at these institutions has enabled him to work on various groundbreaking projects that have significantly impacted the pharmaceutical landscape. Maffrand's expertise in chemical formulations and compound developments has positioned him as a key player in the industry.
Collaborations
Maffrand has collaborated with esteemed colleagues, including Daniel Frehel and Alain Badorc. These partnerships have facilitated the exchange of ideas and resources, contributing to the successful realization of numerous inventions and advancements in pharmaceutical research. Such collaborations are essential in driving innovation forward and fostering a dynamic environment for creativity.
Conclusion
Jean-Pierre Maffrand stands out as a prolific inventor whose contributions to pharmaceutical chemistry are underscored by his extensive patent portfolio. His recent innovations, particularly in developing receptor agonist compounds and therapeutic derivatives, highlight his commitment to enhancing medical therapies. As he continues to collaborate with fellow innovators, Maffrand remains a vital force in the advancement of pharmaceutical sciences.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.